Cyrus Poonawalla on Founder Culture

Wikipedia identifies Cyrus Soli Poonawalla, born 11 May 1941 in a Pune-based Parsi family to parents Soli and Gool Poonawalla, as an Indian billionaire businessman and chairman-managing director of the Cyrus Poonawalla Group. The group includes Serum Institute of India — the world's largest vaccine manufacturer by volume — and Poonawalla Fincorp, a leading Indian NBFC.

Recognition listed by Wikipedia includes the Padma Shri in 2005 for contributions to medicine, the Padma Bhushan in 2022 for contribution in production of vaccines during COVID-19 in the field of Trade and Industry, Ernst & Young's Entrepreneur of the Year for Healthcare & Life Sciences in November 2007 and Entrepreneur of the Year for India in February 2015. The awards trace a two-decade arc that culminated with the COVID-era honor.

Wikipedia notes honorary doctorates from the University of Massachusetts Medical School in June 2018 and the University of Oxford in June 2019, the ICMR Lifetime Achievement Medal for contribution in healthcare conferred by Bill Gates in November 2019, the Lokmanya Tilak National Award in August 2021, and the Dean's Medal from the Johns Hopkins Bloomberg School of Public Health in May 2022.

In 2022, Poonawalla was ranked the 4th richest person in India on the Forbes India rich list with a net worth of $24.3 billion, and was ranked number 1 on the Hurun Global Healthcare Rich List 2022. By October 2024, Forbes listed Poonawalla and his family as the ninth-wealthiest in India with a net worth of $22.1 billion. The wealth trajectory — driven by COVID-era vaccine scale — places him as one of India's richest promoters.

Philanthropy listed by Wikipedia includes a May 2019 proposal, in partnership with Naum Koen, to supply Ukraine with 100,000 doses of measles vaccine for free vaccination during a measles outbreak. In April 2026 Poonawalla acquired Raja Ravi Varma's iconic painting 'Yashoda and Krishna' for a record Rs 167.20 crore at Saffronart's Spring Live Auction in Mumbai —.

Asian Racing Report frames Poonawalla as one of the world's richest men whose horses set him up to make an inconceivable fortune. The interview touches on his passion for breeding and racing, and what he calls the present threat to Indian racing under the Modi government's 28% betting tax on games of chance. The piece is the rare in-depth interview covering the horse-breeding origin of his vaccine business alongside his racing stewardship roles.

Poonawalla owns a pair of Bombardier Global 6500 luxury jets (range 6,500 nautical miles, top speed Mach 0.90, about 690mph), having switched from two Gulfstreams because his son Adar preferred the Global. The personal detail signals the scale of private wealth the vaccine business has produced —.

In Poonawalla's telling to Asian Racing Report, the horses came first: the horses at Poonawalla Stud Farm in the 1960s provided the raw means for him to build a business of global significance — and it did not come from racing or selling them. 'Horse serum. I went into the business of making serums and then vaccines,' he says.

Poonawalla describes the COVID business windfall starkly: before COVID in 2019 he was India's 12th richest person (world rank 76th, fortune US$9.1 billion); by end-2022 he was India's fourth-richest, fortune expanded to US$21.5 billion and climbing — US$22.4 billion at the time of the interview. He frames Serum as one of the largest competitors to Pfizer and the world's biggest vaccine producer by number produced and sold.

Poonawalla tells Asian Racing Report 'the horse business in fact did help me', and he feels a reciprocal responsibility to the thoroughbred industry. He has been vice chairman of the Asian Racing Federation, chairman of the Turf Authorities of India, the Royal Western India Turf Club, the Stud Book Authority of India, and the Indian Pattern Races Committee. The pattern — diversifying into a non-core public role once the core business is built —.

NPR captures the founding story: the property that houses Serum has been a stud farm since 1946, and part of it still is. The Poonawallas are a wealthy family of racehorse breeders (and collectors of luxury cars, including a Batmobile replica). In the 1960s they would donate retired racehorses to the government's Haffkine Institute, which used the horses' blood to develop serums and vaccines.

In 1966 a snake bit one of the Poonawallas' horses. The Haffkine lab had anti-venom serum but needed government permission to administer it — permission that took four days to arrive from Bombay because telephone lines were unreliable. The mare died, and the bureaucratic delay that caused her death gave Cyrus Poonawalla the idea of making the serums himself.